List of Contributors | |
Historical introduction | |
Introduction | |
Overview of Hemostasis | |
Cellular processing of Factor VIII and Factor IX | |
Hemophilia A | |
Molecular Basis of Hemophilia A | |
Phenotypic/genotypic relationship | |
Prophylaxis | |
Continuous Infusion of Coagulation Products in Hemophilia | |
Inhibitors to Factor VIII | |
Inhibitors to Factor VIII - Immunology | |
Genetic and environmental risk factors for FVIII inhibitor development | |
Inhibitors to Factor VIII - Mild and Moderate Hemophilia | |
Inhibitors to Factor VIII/IX: Immune Tolerance | |
Inhibitors to factor VIII: treatment of acute bleeds | |
Acquired Hemophilia | |
Acquired Inhibitors to Factor VIII | |
Hemophilia B | |
Hemophilia B - Molecular Basis | |
Factor IX Inhibitors in Hemophilia B | |
Treatment of Inhibitors in Hemophilia B | |
Pharmacokinetics of Factors VIII & IX | |
Pharmacokinetics | |
Hemophilia - birth to old age | |
The Neonate with Hemophilia | |
Work-up of a Bleeding Child | |
Care of the Child with Hemophilia | |
Adolescence | |
Old age medicine and hemophilia | |
Products used to Treat Hemophilia | |
Products Used to Treat Hemophilia: Recombinant Products | |
Products Used to Treat Hemophilia: Plasma-Derived Coagulation Factor Concentrates | |
Products Used to Treat Hemophilia: Recombinant Factor VIIa | |
Products Used to Treat Hemophilia: Dosing | |
Products Used to Treat Hemophilia: Regulation | |
Musculoskeletal | |
Joint Replacement | |
Synovioarthesis in Hemophilia | |
Pseudotumours in patients with Hemophilia | |
Imaging modalities for assessment of hemophilic arthropathy | |
Physiotherapy in the Management of Hemophilia | |
Clinimetric Instruments in Haemophilia | |
Transfusion-Transmitted Disease | |
Hepatitis C Virus Infection and Liver Transplantation | |
Emerging Infections | |
Gene Therapy | |
Hemophilia Gene Therapy: An overview | |
Gene Therapy Trials | |
Gene Therapy: Molecular Engineering of Factor VIII and Factor IX | |
Laboratory | |
Laboratory Assays in Hemophilia | |
Standardization of Assays | |
Global laboratory assays in Haemophilia | |
Obstetrics & Gynaecology | |
Obstetrics and Gynecology: Hemophilia | |
Von Willebrand Disease | |
von Willebrand Disease: Molecular Aspects | |
von Willebrand Disease: Epidemiology | |
von Willebrand Disease: Biological Diagnosis | |
Classification and Clinical Aspects of von Willebrand Disease | |
Treatment of Von Willebrand Disease | |
Treatment of von Willebrand Disease: Desmopressin | |
Treatment of von Willebrand Disease: Therapeutic Concentrates | |
Women & Von Willebrand Disease | |
Rare Bleeding Disorders | |
Factor II | |
Factor V and combined Factor V and VIII Deficiencies | |
Congenital Factor VII Deficiency | |
Factor X Deficiency | |
Factor XI Deficiency | |
Factor XIII Deficiency | |
Fibrinogen Deficiency | |
Miscellaneous Rare Bleeding Disorders | |
Emergency medicine | |
Emergency Medicine and Inherited Blood Disorders | |
Quality of Life | |
Quality of Life in Hemophilia | |
Economics | |
The Economics of Hemophilia Treatments | |
Comprehensive Care and Delivery of Care | |
National Haemophilia Databases | |
Comprehensive Care and the Delivery of Care: The Developed World | |
Comprehensive care and delivery of care in haemophilia: The Developing World | |
Comprehensive Care and Delivery of Care: The Global Perspective | |
Index | |
Table of Contents provided by Publisher. All Rights Reserved. |
The New copy of this book will include any supplemental materials advertised. Please check the title of the book to determine if it should include any access cards, study guides, lab manuals, CDs, etc.
The Used, Rental and eBook copies of this book are not guaranteed to include any supplemental materials. Typically, only the book itself is included. This is true even if the title states it includes any access cards, study guides, lab manuals, CDs, etc.